Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Richard T. Hoppe(Stanford Medicine), Hema Sundar(National Comprehensive Cancer Network), Joachim Yahalom(Unknown), Bouthaina S. Dabaja, Leo I. Gordon(Northwestern University), David G. Maloney(Fred Hutch Cancer Center), Karl Bernat, Monika L. Metzger(St. Jude Children's Research Hospital), Matthew M. Poppe(University of Utah), Peter Mauch(Western Sydney University), Vaishalee P. Kenkre(University of Wisconsin–Madison), Jennifer L. Burns(National Comprehensive Cancer Network), Rachel Rabinovitch(University of Colorado Boulder), Ephraim P. Hochberg(Massachusetts General Hospital), Andres Forero(University of Alabama at Birmingham), Weiyun Z. Ai(City College of San Francisco), Kristie A. Blum(Emory University), Ranjana H. Advani(Stanford Medicine), David Morgan(Vanderbilt University Medical Center), Ndiya Ogba(National Comprehensive Cancer Network), Francisco J. Hernandez‐Ilizaliturri(Roswell Park Comprehensive Cancer Center), Richard F. Ambinder(Johns Hopkins University), Carolyn Mulroney(University of California San Diego Medical Center), Patricia Aoun(University of Nebraska Medical Center), Nadia Khan(Fox Chase Cancer Center), Patrick B. Johnston(Mayo Clinic in Arizona), Mark Kaminski(Sheba Medical Center), Cecil M. Benitez(Cancer Institute (WIA)), Mitchell R. Smith, Robert Chen(AstraZeneca (United States)), Jiayi Huang(Chongqing Medical University), Joseph O. Moore(Cancer Institute (WIA)), Philip J. Bierman(Susan Thompson Buffett Foundation), Stuart Seropian(Yale Cancer Center), Craig H. Moskowitz(University of Miami), Celeste Bello(Moffitt Cancer Center), Jane N. Winter(Northwestern University)
Cited by 142
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k